
Keywords: GBC, gallbladder cancer; GSD, gall stone diseases; MASPIN, mammary serine protease inhibitor; HLTF, helicase like transcription factor; COX2, cyclooxygenase2; SOCS1, suppressor of cytokine signalling 1; FLNC, filamin C; THBS1, thrombospondin1; IHC, Immuno